VRSK(VRSK)
VRSK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $3.22B | $3.44B | $3.67B | $3.93B | $4.22B |
| Low | $3.21B | $3.40B | $3.61B | $3.89B | $4.19B |
| High | $3.23B | $3.47B | $3.70B | $3.96B | $4.25B |
| EBITDA Avg | $1.85B | $1.98B | $2.11B | $2.26B | $2.43B |
| Low | $1.85B | $1.96B | $2.08B | $2.24B | $2.41B |
| High | $1.86B | $2.00B | $2.13B | $2.28B | $2.45B |
| EBIT Avg | $1.47B | $1.57B | $1.67B | $1.79B | $1.92B |
| Low | $1.46B | $1.55B | $1.64B | $1.77B | $1.91B |
| High | $1.47B | $1.58B | $1.69B | $1.80B | $1.94B |
| Net Income Avg | $1.06B | $1.21B | $1.35B | $1.51B | $1.68B |
| Low | $1.05B | $1.17B | $1.31B | $1.50B | $1.66B |
| High | $1.08B | $1.25B | $1.39B | $1.53B | $1.70B |
| EPS Avg | $7.70 | $8.69 | $9.76 | $10.88 | $12.09 |
| Low | $7.53 | $8.43 | $9.39 | $10.75 | $11.95 |
| High | $7.78 | $8.97 | $10.00 | $10.98 | $12.20 |
| Analysts (Rev / EPS) | 12 / 13 | 13 / 13 | 11 / 7 | 5 / 2 | 5 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $806M | $825M | $837M | $861M | $862M | $879M | $895M | $922M |
| Low | $802M | $814M | $829M | $854M | $855M | $872M | $887M | $914M |
| High | $815M | $837M | $847M | $872M | $873M | $890M | $906M | $933M |
| EBITDA Avg | $465M | $475M | $482M | $496M | $497M | $506M | $516M | $531M |
| Low | $462M | $469M | $478M | $492M | $492M | $502M | $511M | $526M |
| High | $469M | $482M | $488M | $502M | $503M | $513M | $522M | $538M |
| EBIT Avg | $367M | $376M | $381M | $392M | $393M | $400M | $408M | $420M |
| Low | $365M | $371M | $378M | $389M | $389M | $397M | $404M | $416M |
| High | $371M | $381M | $386M | $397M | $398M | $405M | $413M | $425M |
| Net Income Avg | $252M | $259M | $270M | $289M | $285M | $292M | $298M | $321M |
| Low | $250M | $237M | $267M | $286M | $282M | $289M | $294M | $317M |
| High | $256M | $268M | $274M | $294M | $290M | $297M | $303M | $326M |
| EPS Avg | $1.93 | $1.98 | $2.06 | $2.21 | $2.18 | $2.23 | $2.28 | $2.45 |
| Low | $1.91 | $1.81 | $2.04 | $2.19 | $2.15 | $2.21 | $2.25 | $2.43 |
| High | $1.96 | $2.05 | $2.09 | $2.25 | $2.21 | $2.27 | $2.31 | $2.49 |
| Analysts (Rev / EPS) | 9 / 11 | 9 / 11 | 7 / 4 | 4 / 4 | 4 / 7 | 7 / 4 | 7 / 5 | 3 / 6 |